3417
螟ァ譛ィ繝倥Ν繧ケ繧ア繧「繝帙�シ繝ォ繝�繧」繝ウ繧ー繧ケ譬ェ蠑丈シ夂、セ
大木ヘルスケアホールディングス株式会社Ohki Healthcare Holdings Co.,Ltd. engages in the manufacture and sale of pharmaceuticals and other products. The company is involved in the sale, import, and export of pharmaceuticals, quasi-drugs, medical equipment, cosmetics, poisons, deleterious substances, chemicals, reagents, measuring instruments, optical equipment, electrical appliances, and communication equipment; and veterinary drugs, veterinary quasi-drugs, veterinary medical equipment, pet supplies, feed, and feed additives. It also sells, imports, and exports textile products, hygiene products, cosmetics, beauty products, health equipment, sporting goods, leisure goods, nursing care products, convenient nursing care products, toys, stationery, household goods, daily necessities, food products, food additives, alcoholic beverages, rice, salt, and tobacco; and sale of pesticides, fertilizers, gardening supplies, and agricultural supplies. In addition, the company engages in warehouse operations; development, sale, and rental of information processing systems, logistics system equipment, and software; management and dispensing of pharmacies and drugstores; provision of nursing care services; manufacturing of sanitary products and soft drinks; and manufacture and wholesale of products, such as the polystyrene foam volume reduction liquid, Ecokaton 50-IPS and the antibacterial and disinfectant, Power Anti. Further, it is involved in the wholesale of food and contact lenses, as well as cosmetics and miscellaneous goods; retail of pharmaceuticals; and application for licenses and permits. Ohki Healthcare Holdings Co.,Ltd. was founded in 1658 and is headquartered in Tokyo, Japan.
Price
¥1,114
Market Cap
¥15.2B
Ent. Value
¥26.5B
Net Debt
−¥11.3B
Shares Out.
13.6M
P / E
5.8×
EV / EBIT
9.6×
⚠ TSE Capital Mandate
P / Book
0.49×
P / NCAV
1.99×
Div. Yield
2.33%
Financials
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|
| Net Sales | ¥349.5B | ¥334.7B | ¥304.4B | ¥278.2B |
| Cost of Sales | ¥330.9B | ¥317.5B | ¥288.6B | ¥264.4B |
| Gross Profit | ¥18.5B | ¥17.2B | ¥15.9B | ¥13.7B |
| SG&A | ¥15.7B | ¥15.2B | ¥13.8B | ¥13.1B |
| Operating Income | ¥2.8B | ¥2.0B | ¥2.1B | ¥631M |
| Non-Operating Income | ¥1.4B | ¥1.3B | ¥1.2B | ¥1.1B |
| Dividend Income | ¥195M | ¥172M | ¥158M | ¥163M |
| Interest Income | ¥27M | ¥31M | ¥25M | ¥22M |
| Non-Operating Expenses | ¥129M | ¥67M | ¥67M | ¥119M |
| Interest Expense | ¥65M | ¥35M | ¥33M | ¥36M |
| Ordinary Income | ¥4.0B | ¥3.3B | ¥3.2B | ¥1.6B |
| Pre-tax Income | ¥3.8B | ¥3.4B | ¥3.2B | ¥1.5B |
| Income Taxes | ¥1.2B | ¥1.3B | ¥998M | ¥605M |
| Current Tax | ¥1.3B | ¥1.4B | ¥1.0B | ¥847M |
| Deferred Tax | ¥-111M | ¥-108M | ¥-6M | ¥-119M |
| Net Income (owners) | ¥2.6B | ¥2.2B | ¥2.2B | ¥972M |
| Minority Interest | ¥4M | ¥-83M | ¥1M | ¥-45M |
| Comprehensive Income | ¥3.5B | ¥4.1B | ¥2.5B | ¥242M |
| EBITDA | ¥3.2B | ¥2.4B | ¥2.4B | ¥1.0B |
| EPS | ¥193.49 | ¥160.45 | ¥158.22 | ¥70.51 |
| Shares Outstanding | 13.6M | 13.6M | 13.8M | 13.8M |
| Shares Issued (total) | 14.1M | 14.1M | 14.1M | 14.1M |
| Treasury Shares | 0.4M | 0.4M | 0.3M | 0.3M |